Recombinant Human PRDX5 (N-6His)

Description

EnkiLife provides the Recombinant Human PRDX5 (N-6His) protein,aslo know as Peroxiredoxin-5,PRDX5,Alu corepressor 1,Antioxidant enzyme B166,AOEB166,Liver tissue 2D-page spot 71B,PLP,Peroxiredoxin V,Prx-V,Peroxisomal antioxidant enzyme,TPx type VI,Thioredoxin peroxidase PMP20,Thioredoxin reductase, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Peroxiredoxin-5 is produced by our Mammalian expression system and the target gene encoding Met53-Leu214 is expressed with a 6His tag at the N-terminus.Accession:P30044. Expression Host:Human Cells.Species:Human.Predicted Molecular Mass:17.9 KDa. Background:Peroxisomes are essential organelles that participate in multiple important metabolic processes, including the β-oxidation of fatty acids, plasmalogen synthesis, and the metabolism of reactive oxygen species (ROS). Peroxiredoxins is overexpressed in breast cancer tissues to a great extent suggesting that they has a proliferative effect and may be related to cancer development or progression. Peroxiredoxin 5 (PRDX5) is a thioredoxin peroxidase that belongs to the atypical 2-Cys class of the TSA/ahpC family of peroxiredoxins. PRDX5 is a widely expressed mitochondrial antioxidant enzyme that reduces hydrogen peroxide, alkyl hydroperoxides, and peroxynitrite. In human cells, this enzyme is present in the cytosol, mitochondria, peroxisomes, and nucleus.